MDGL · Madrigal Pharmaceuticals, Inc. · Share Buybacks
$421.99
-1.97 (-0.46%)
At close · Nov 17
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$9.80B
Shares
23.23M
Volume · Nov 17
364.74K
Avg daily vol (3M)
358.96K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-05 | — | $300,000,000 | $300,000,000 as of 2026-09-30 | — | 10-Q , filed 2026-11-03 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2012-12-31 | $32,000 | 10-K, filed 2015-03-12 |
Key facts
CIK
1157601
CUSIP
558868105
13F (30d)
453 filings
415 filers
Visit website
Investor relations